National Comprehensive Cancer Network

Clinical Recommendations

JNCCN Task Force Supplements

NCCN convenes experts from within and beyond NCCN Member Institutions to expand on issues discussed in the NCCN Guidelines and to discuss issues outside the scope of the NCCN Guidelines.

2009 Supplements

• NCCN Task Force Report: Management of Dermatologic and Other Toxicities Associated With EGFR Inhibition in Patients With Cancer
• NCCN Task Force Report: Clinical Utility of PET in a Variety of Tumor Types
• NCCN Task Force Report: Bone Health in Cancer Care

2008 Supplements

• Breast Cancer in the Older Woman
• mTOR Inhibition in Solid Tumors
• Oral Chemotherapy
• Prevention and Management of Mucositis in Cancer Care

2007 Supplements

• Gastrointestinal Stromal Tumors (GISTs)
• PET/CT Scanning in Cancer

2006 Supplements

• NCCN Task Force Report: Adjuvant Therapy for Breast Cancer
• NCCN Task Force Report: Bone Health and Cancer Care
• HER2 Testing in Breast Cancer: NCCN Task Force Report and Recommendations

* Please see individual task force report for more information on CME/CE credits.

These files are for individual use only; printing out multiple copies is strictly prohibited. You may not reproduce and/or distribute any file in other formats or media or for any other purposes. For multiple copies/reprints, please contact David Horowitz.

Each JNCCN supplement is copyrighted by the National Comprehensive Cancer Network. All rights reserved. This file may not be used for any other purposes without further permission from the National Comprehensive Cancer Network. Permission can be requested at here.

You are not permitted to translate, reformat, add to, rearrange, delete pages, extract portions, modify, adapt, or change any parts of this file without further permission from the National Comprehensive Cancer Network.

You are not permitted to place advertisements or logos of any kind on or within this file.

You are not permitted to distribute this file electronically (including via internet, CD-ROM, PDA, DVD, etc...).